FreedomWorks Foundation Statement in Response to the White House Decision to Sign Buy American Executive Order
WASHINGTON, D.C. — In response to the White House issuing a Buy American executive order for pharmaceutical products, Adam Brandon, FreedomWorks President, commented:
“A sheer 72 percent of the supply chain for active pharmaceutical ingredients is based overseas. This executive order threatens to disrupt not only a major sector of our economy, but one that is integral to fighting the COVID crisis. This will be an incredibly costly, harmful measure if implemented.
“Much of the good this administration has done has stemmed from the instinct to let private industry operate without the heavy hand of government. This order cuts directly against that recipe for success and we urge the administration to reconsider the consequences of this executive action.”